Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Palliative Medicine|June 21, 2021
Factors related to spiritual well-being in the last days of life in three East Asian countries: An international multicenter prospective cohort studyYusuke Hiratsuka, Sang-Yeon Suh, Sun-Hyun Kim, et al.
BMC Psychiatry|June 2, 2025
Interaction effect of comorbid depression and proactive positivity coping strategy on the 1-year survival of patients with advanced cancer: a nationwide multicentre study in South KoreaJu Youn Jung, Je-Yeon Yun, Jung Hun Kang, et al.
Cancer Research and Treatment|April 13, 2023
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel ChemotherapyYoung-Woong Won, Jin-Hyoung Kang, Jung Hye Kwon, et al.
Expert Opinion on Biological Therapy|April 26, 2024
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance studyMin Ho Park, Jae Hong Seo, Jung Ho Park, et al.
Cancer Research and Treatment|August 5, 2016
Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study ResultsYeon Hee Park, Tae Yong Kim, Young-Hyuck Im, et al.
Cancers|August 7, 2021
Cancer Patients' Willingness to Take COVID-19 Vaccination: A Nationwide Multicenter Survey in KoreaJune Young Chun, Se Ik Kim, Eun Young Park, et al.
Cancer Research and Treatment|January 18, 2019
Prospective Validation of The Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative ChemotherapyJin Won Kim, Se Hyun Kim, Yun-Gyoo Lee, et al.
Palliative & Supportive Care|September 16, 2022
Comparison of Objective Prognostic Score and Palliative Prognostic Score performance in inpatients with advanced cancer in Japan and KoreaYusuke Hiratsuka, Daye Kim, Sang-Yeon Suh, et al.
The Lancet. Oncology|November 1, 2019
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trialYeon Hee Park, Tae-Yong Kim, Gun Min Kim, et al.
British Journal of Cancer|March 27, 2018
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective studyJin Won Kim, Yun-Gyoo Lee, In Gyu Hwang, et al.
Pageof 11